Clinical Trial Update: E. Coli Nissle 1917 - Suspension for Infection Prophylaxis [Phase 3]

View source ↗

Summary

Phase 3 trial update regarding E. coli Nissle 1917 suspended for infection prophylaxis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection

Drugs mentioned

• E. coli Nissle 1917 (Escherichia coli Nissle 1917)

Snippet

Sponsor: Ardeypharm GmbH | Conditions: Infections | Phase 3 | Status: COMPLETED